Den teknologiske udviklings mulige miljøkonsekvenser

Biotechnology - health sector

 

 

00

01

02

03

04

05

06

07

08

09

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

Health care systems

 

prevention programmes and standards for diet and lifestyle

 

 

financial inducement for healthy lifestyle

transparent evaluation, validation and accounting system for treatment implementation / adoption of alternative treatment methods

 

 

market growth for nutriceuticals

 

ICT

 

50% of treatment involves use of expert systems

 

 

electronic network and databases for patient records, treatment, and disease monitoring

 

 

register for cancer

 

predicting protein function from gene sequence computer simulation of drugs

 

Therapies

nutritional supplements or diets for cancer prevention

drugs prevent the occurrence of certain cancers

 

 

pathogenesis of Alzheimer’s and other neurodegenerative diseases is solved

 

 

AIDS vaccine

 

medication of viral diseases

 

 

new treatment methods for myocardial diseases

molecular etiology for Hypertonia, Diabetes, Arteriosclerosis is identified

 

 

risk assessment for cardiovascular diseases

 

 

diabetes drug for oral application

 

 

tissue specific polypeptide drugs

 

 

application of somatic gene therapies for single gene defects

 

 

biocompatible and biodegradable splints for bone fractures

 

Diagnosis

genetic testing accounts for 10% of diagnosis work load

 

 

gene test are sold ‘over the counter’

 

non-invasive cell level diagnostic imaging

 

 

regulatory framework for non-laboratory diagnostic kits

 

 

biosensors (based e.g. on antibodies) are in use